United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bevacizumab 1.25mg/0.05ml solution for injection vials
special order - bevacizumab - solution for injection - 25mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes
special order - bevacizumab - solution for injection - 25mg/1ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bevacizumab 1% eye drops
special order - bevacizumab - eye drops - 10mg/1ml
Tanzania -
English -
Tanzania Medicinces & Medical Devices Authority
bevacizumab amring solution for injection/concentrate for solution for infusion 25 mg/ml
amring farma s.r.l, romania - bevacizumab - solution for injection/concentrate for solution for infusion - 25 mg/ml
Tanzania -
English -
Tanzania Medicinces & Medical Devices Authority
bevacizumab amring solution for injection/concentrate for solution for infusion 25 mg/ml
amring farma s.r.l, romania - bevacizumab - solution for injection/concentrate for solution for infusion - 25 mg/ml
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bevacizumab 5mg/0.2ml solution for injection pre-filled syringes
special order - bevacizumab - solution for injection - 25mg/1ml
Uganda -
English -
National Drug Authority
bevacizumab amring 100 mg/4 ml parenteral ordinary vials
amring farma s.r.l - bevacizumab - parenteral ordinary vials - 100 mg/4 ml
Uganda -
English -
National Drug Authority
bevacizumab amring 400 mg/16 ml parenteral ordinary vials
amring farma s.r.l - bevacizumab - parenteral ordinary vials - 400 mg/16 ml
Kenya -
English -
Pharmacy and Poisons Board
bevaas 100 concentrate for solution for injection
m/s. hetero biopharma limited sy. no. 458 (part), tsiic-formulation sez, - bevacizumab - concentrate for solution for injection - bevacizumab 100 mg/4ml - bevacizumab
Kenya -
English -
Pharmacy and Poisons Board
bevaas 400 concentrate for solution for injection
m/s. hetero biopharma limited sy. no. 458 (part), tsiic-formulation sez, - bevacizumab - concentrate for solution for injection - bevacizumab 400mg/16ml - bevacizumab